NCT04028128

Brief Summary

The decrease in body fat percentage improves exercise performance, reducing race time. The intake of cocoa improves the body fat composition in obese and diabetic people by improving their cardiovascular disease risk factors. Although epidemiological studies indicate that healthy subjects who consume cocoa have lower body fat composition, there is no study indicating whether cocoa improves fat composition in athletes. The aim of the study was to determine if the intake of cocoa rich in flavonoids improves the fat composition of athletes, modifying the systemic levels of adipokines (folistatin, myostatin and leptin), resulting in an improvement of physical performance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 18, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 22, 2019

Completed
Last Updated

September 26, 2019

Status Verified

September 1, 2019

Enrollment Period

1.1 years

First QC Date

July 18, 2019

Last Update Submit

September 24, 2019

Conditions

Keywords

Nutritional SupplementHigh in flavanoids cocoaBody Fat compositionPhysical Exercise performance

Outcome Measures

Primary Outcomes (1)

  • Change of body fat mass at 10 weeks

    Energy X-ray absorptiometry (DEXA).

    Fat mass was analyzed at the beginning (baseline time = 0) and after 10 weeks of intervention

Secondary Outcomes (7)

  • Change of lean mass at 10 weeks

    Lean mass was analyzed at the beginning (baseline time) and after 10 weeks of intervention

  • Change in Sport performance test at 10 weeks

    Sport performance was analyzed at the beginning (baseline time) and after 10 weeks of intervention

  • Change in Sport performance test 2 at 10 weeks

    Sport performance was analyzed at the beginning (baseline time and after 10 weeks of intervention

  • Change from baseline of adipokines at 10 weeks

    Myostatin and Follistatin were analyzed at the beginning and at the end of the 10-week intervention.

  • Change from baseline of leptin

    Leptin was analyzed at the beginning and at the end of the 10-week intervention.

  • +2 more secondary outcomes

Study Arms (2)

Cocoa group

EXPERIMENTAL

The cocoa was provided in 5 g sachets. The intervention last 10 weeks. Cocoa was provided in a single daily dose of 5 g, which provided 425 mg of flavonoids

Dietary Supplement: Cocoa group

Placebo group

PLACEBO COMPARATOR

Maltodextrin (5 g) was supplied as placebo in sachets identical to those provided for cocoa.

Dietary Supplement: Placebo group

Interventions

Cocoa groupDIETARY_SUPPLEMENT

Athletes performed a training program and consumed 5 g of cocoa (425 mg of flavonoids) mixed with semi-skimmed fat milk, daily for 10 weeks.

Cocoa group
Placebo groupDIETARY_SUPPLEMENT

The athletes performed the same training program of the cocoa group and they took for 10 weeks 5 g of maltodextrin mixed with semi-skimmed fat milk.

Placebo group

Eligibility Criteria

Age18 Years - 50 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsHigh performance sportsmen
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Men.
  • Age between 18 and 50 years
  • Aerobic power of oxygen consumption greater than or equal to 55 mL / kg / min

You may not qualify if:

  • Intake of chronical medication.
  • Intake any type of nutritional or ergogenic supplements.
  • Vegetarian or vegan diet
  • Smoke.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jose Ángel García Merino

Villaviciosa de Odón, Madrid, 28670, Spain

Location

Study Officials

  • María del Mar Larrosa Pérez, PhD

    Universidad Europea de Madrid

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Cocoa and maltodextrin (placebo) are provided in identical sachets which are identified with the letters A and B respectively.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Placebo controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Tenure Professor

Study Record Dates

First Submitted

July 18, 2019

First Posted

July 22, 2019

Study Start

January 1, 2018

Primary Completion

February 20, 2019

Study Completion

April 1, 2019

Last Updated

September 26, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations